New lung tests could reveal how skipping airway clearance affects CF patients

NCT ID NCT06339593

First seen Jan 17, 2026 · Last updated Jun 13, 2026 · Updated 20 times

Summary

This study looks at new ways to measure lung changes in people with cystic fibrosis (CF) when they stop and restart their usual airway clearance treatments. Researchers will use special MRI scans with a breathable gas called Xenon and a breathing test called LCI to see how the lungs are working. About 60 people aged 12-21 with CF who take Trikafta will take part. The goal is to learn more about these new tests, not to provide a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cincinnati Children's Hospital

    RECRUITING

    Cincinnati, Ohio, 45229, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.